They also confirmed that the activation of NF‐κB and STAT3 induced by IKBKE was associated with the expression of CCL5 (chemokine ligand 5) and promoted tumorigenicity and progression of breast cancer through these pathways. This evidence concerns the gene NFKB1 and breast carcinoma.